EP 4271381 A1 20231108 - METHODS OF TREATING PSYCHIATRIC DISORDERS IN OBESE PATIENTS WITH BREXPIPRAZOLE
Title (en)
METHODS OF TREATING PSYCHIATRIC DISORDERS IN OBESE PATIENTS WITH BREXPIPRAZOLE
Title (de)
VERFAHREN ZUR BEHANDLUNG VON PSYCHIATRISCHEN ERKRANKUNGEN BEI FETTLEIBIGEN PATIENTEN MIT BREXPIPRAZOL
Title (fr)
MÉTHODES DE TRAITEMENT DE TROUBLES PSYCHIATRIQUES PAR BREXPIPRAZOLE CHEZ DES PATIENTS OBÈSES
Publication
Application
Priority
- US 202017139627 A 20201231
- US 202017139690 A 20201231
- US 2021016329 W 20210203
Abstract (en)
[origin: WO2022146462A1] The present disclosure relates to methods of initiating brexpiprazole treatment in patients with schizophrenia or major depressive disorder. The present disclosure further relates to modified dosing regimens for obese patients and/or patients that are CYP2D6 poor metabolizers. In embodiments, the modified dosing regimens administers double the daily dose while initiating treatment.
IPC 8 full level
A61K 31/496 (2006.01)
CPC (source: EP)
A61K 31/496 (2013.01)
Citation (search report)
See references of WO 2022146462A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022146462 A1 20220707; AU 2021412785 A1 20230622; CA 3201123 A1 20220707; EP 4271381 A1 20231108; JP 2024502431 A 20240119
DOCDB simple family (application)
US 2021016329 W 20210203; AU 2021412785 A 20210203; CA 3201123 A 20210203; EP 21916093 A 20210203; JP 2023540740 A 20210203